A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer.

  • Zhang, Alison (Primary Chief Investigator)
  • Chapman, Nicola (Chief Investigator)
  • Butala, Radhika (Chief Investigator)

Project: Other

Project Details

Short titleCA017-078
Effective start/end date6/08/1918/06/24